Stefano Rinaldi has a diverse work experience in the field of scientific research. Stefano started their career as a PhD student at the University of Rome "Tor Vergata", where they focused on investigating the response to influenza vaccination in HIV-1 infected children and kidney transplanted patients. During this time, they also collaborated with pediatric children Hospital "Bambino Gesù" on a project about vaccination's response and aging in immunocompromised children, particularly those with HIV. Additionally, they spent a year as a research scholar with the CFAR of Miami, where they delved into the transcriptomics of the immune response and immune aging in HIV-infected patients.
After completing their PhD, Stefano joined the University of Miami as a Postdoctoral Associate, working on projects related to the immune response and aging. Stefano later transitioned to the role of Research Scholar, where they continued their research in this field.
In 2021, Stefano joined Fuhong Therapeutics as a Senior Scientist I, where they likely focused on research and development in the biotechnology sector. Stefano held this position until 2022, when they joined Dragonfly Therapeutics, Inc. as a Senior Scientist I. The details of their role at this company are not specified.
Overall, Stefano's work experience showcases their expertise in scientific research, particularly in the areas of immunology, vaccination response, and immune aging.
Stefano Rinaldi has a strong educational background in the field of biology and immunology. Starting in 2006, they attended the University of Rome Tor Vergata and earned a Bachelor of Science (B.Sc.) degree in Human Biology in 2010. Stefano then pursued a Master of Science (MSc) degree in the same field, which they completed in 2012. Following this, Stefano continued their education at the University of Rome Tor Vergata and obtained a Doctor of Philosophy (PhD) degree in Immunology and applied biotechnology in 2015.
In addition to their academic achievements, Stefano holds a diploma from Liceo Scientifico Talete, where they completed their high school education in the scientific stream with a special focus on the scientific project of Professor Brocca.
Furthermore, Stefano has a certification called P.E.T. (Preliminary English Test) from Cambridge English Language Assessment, which they obtained in February 2015.
Sign up to view 0 direct reports
Get started